Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality

Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality

Yanzi Cheng,1 Jiwen Zhong,1 Yang Xiang,1 Fan Zeng,1 Dehong Cai,2,&dagger; Ling Zhao11Department of Intensive Care Unit, Zhuhai People’s Hospital, Zhuhai, Guangdong, People’s Republic of China; 2Department of Endocrinology, Zhujiang Hospital of Southern Medical University, Gua...

Full description

Bibliographic Details
Main Authors:	Cheng YZ, Zhong JW, Xiang Y, Zeng F, Cai DH, Zhao L
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-11-01
Series:	Clinical Interventions in Aging
Subjects:	Soluble receptor for advanced glycation end products advanced glycation end products critically ill patients;clinical marker;prognosis
Online Access:	https://www.dovepress.com/soluble-receptor-for-advanced-glycation-end-products-in-critically-ill-peer-reviewed-article-CIA

Similar Items

Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
by: Yu Peng, et al.
Published: (2022-12-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
by: Shou-En Wu, et al.
Published: (2021-10-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study
by: Yu Wing Tong, et al.
Published: (2023-05-01)

The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts
by: Monika Czech, et al.
Published: (2021-05-01)

Sputum–plasma ratio of soluble receptor for advanced glycation end-products in patients with chronic obstructive pulmonary disease
by: Essam Gouda Hassanein, et al.
Published: (2016-07-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Comparative evaluation of Salivary-Soluble Receptor for Advanced Glycation End Product (sRAGE) levels among betel chewers and chronic periodontitis patients
by: Rajkumar Chandini, et al.
Published: (2021-01-01)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

Antioxidant and anti-advanced glycation end products formation properties of palmatine
by: Sharma Mridula, et al.
Published: (2021-05-01)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
by: Kosuke Saku, et al.
Published: (2020-07-01)

Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer
by: Ziling Mao, et al.
Published: (2021-12-01)

Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
by: Takanobu Takata, et al.
Published: (2020-06-01)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
by: Parisa Younessi, et al.
Published: (2011-09-01)

Antiglycation potential of commercial available extracts of two Indian medicinal plants: Pterocarpus marsupium and Artocarpus lakoocha using advanced glycation end products (AGE) competitive fluorescence assay
by: Alpana Pande, et al.
Published: (2021-01-01)

Colorimetric and fluorometric profiling of advanced glycation end products
by: Ammanath, Gopal, et al.
Published: (2022)

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
by: Hiroyasu Mori, et al.
Published: (2019-09-01)

Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
by: William H. Hoffman, et al.
Published: (2020-06-01)

Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease
by: Melpomeni Peppa, et al.
Published: (2021-09-01)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
by: Lin Mao, et al.
Published: (2022-08-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

Advanced Glycation End Products and Psoriasis
by: Martina Maurelli, et al.
Published: (2023-03-01)

A novel crosslinked type of advanced glycation end-product derived from lactaldehyde
by: Tomoaki Shigeta, et al.
Published: (2020-11-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
by: Xiaohai Zhou, et al.
Published: (2020-11-01)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
by: Taehee Kim, et al.
Published: (2023-05-01)

The effect of protein oxidation on the formation of advanced glycation end products after chicken myofibrillar protein glycation
by: Zongshuai Zhu, et al.
Published: (2023-09-01)

Anti-inflammaging effects of vitamin D in human gingival fibroblasts with advanced glycation end product stimulation
by: Hung-Chieh Lu, et al.
Published: (2023-04-01)

Serum Levels of Antibodies to Advanced Glycation End Products in Patients with Type 2 Diabetes Mellitus and Hypertension
by: Asparuh Nikolov, et al.
Published: (2020-06-01)

Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors
by: Wenge Zheng, et al.
Published: (2022-11-01)

Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus
by: Kathryn C.B. Tan, et al.
Published: (2008-07-01)

Correlation between advanced glycation end-products and the expression of fatty inflammatory factors in type II diabetic cardiomyopathy
by: Zhengdong Guo, et al.
Published: (2015-10-01)

Association of advanced glycation end products in Dupuytren disease
by: Fumiaki Takase, et al.
Published: (2018-06-01)

The Protective Effect of Brazilian Propolis against Glycation Stress in Mouse Skeletal Muscle
by: Tatsuro Egawa, et al.
Published: (2019-09-01)

Higher Dietary Intake of Advanced Glycation End Products Is Associated with Faster Cognitive Decline in Community-Dwelling Older Adults
by: Michal Schnaider Beeri, et al.
Published: (2022-03-01)